The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.75
Ask: 7.25
Change: -0.25 (-3.45%)
Spread: 0.50 (7.407%)
Open: 7.50
High: 7.25
Low: 7.00
Prev. Close: 7.25
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Joules up on upbeat outlook; Numis quarter slow

Tue, 08th Feb 2022 11:46

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Joules Group PLC, up 15% at 60.00 pence, 12-month range 51.00p-310.00p. The lifestyle brand posts a jump in interim revenue and expresses confidence in its long-term prospects. For six months to November 28, revenue was GBP127.9 million, up 35% from GBP94.5 million year before and pretax profit doubles to GBP2.6 million from GBP1.3 million. Looking ahead, Joules says it remains confident in ability to deliver profitable growth for financial 2023. Last week, the stock had hit a 12-month low, falling 46% in one day, after Joules warned on annual profit and said that revenue over the Christmas period and January was lower than it had expected.

----------

Midwich Group PLC, up 5.7% at 634.00p, 12-month range 420.00p-700.00p. The audio-visual distributor has agreed to acquire specialist communication technology company Nimans. Midwich will acquire Nimans from Nycomm Holdings for GBP27.5 million in cash, funded from existing cash reserves.

----------

Ixico PLC, up 3.3% at 47.00p, 12-month range 45.10p-115.00p. The medical imaging company wins a GBP1 million contract to provide PET and MRI imaging services to an unnamed European biopharmaceutical company specialising in neurodegenerative conditions.

----------

AIM - LOSERS

----------

Numis Corp PLC, down 3.7% at 286.00p, 12-month range 274.00p-419.86p. Shares hit 12-month low as the corporate broker saw slower start to its second quarter amid damped risk appetite among investors concerned by surging inflation and rising interest rates. Numis says: "Mounting inflation and interest rate concerns have impacted broader equity markets in recent weeks, with a reduction in investor risk appetite and capital markets activity. As such, we have had a slower start to our second quarter, albeit our pipeline and outlook for the second half across both M&A and Capital Markets is encouraging."

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
21 Aug 2018 10:44

WINNERS & LOSERS SUMMARY: Persimmon Leads Housebuilders Higher

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 1.3%. The housebuilder said it continued to

Read more
21 Aug 2018 10:05

IXICO Shares Jump As It Expects 24% Rise In Full-Year Revenue

LONDON (Alliance News) - Shares in IXICO PLC rose on Tuesday as the company said it expects 24% jump in annual revenue, ahead of market expectations.IXICO shares were trading up 16% at the

Read more
21 Aug 2018 07:56

IXICO says full year will be ahead of market expectations

(Sharecast News) - Data science company IXICO said on Tuesday that trading for the year to 30 September is now expected to be ahead of market expectations.

Read more
13 Aug 2018 11:10

IXICO Expands Clinical Trial Study Contract To GBP1.6 Million

LONDON (Alliance News) - IXICO PLC said Monday it signed an expansion to an existing trial study contract with an unnamed pharmaceutical company, worth GBP600,000.The additional services to

Read more
13 Aug 2018 08:03

IXICO expands contract with top 10 pharmaceutical company

(Sharecast News) - AIM-listed data science company IXICO has signed an expanded scope to a current contract with a top 10 pharmaceutical company three months into the contract.

Read more
12 Jun 2018 12:03

UPDATE: AstraZeneca Discontinues Alzheimer's Disease Treatment Trial

LONDON (Alliance News) - AstraZeneca PLC said Tuesday it has decided to discontinue trials of a new drug for Alzheimer's disease as the treatment is unlikely to meet its primary test UK listed

Read more
12 Jun 2018 10:52

WINNERS & LOSERS SUMMARY: Crest Nicholson Woes Topple Housebuilders

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 2.1%. Jefferies raised the energy services a

Read more
12 Jun 2018 08:30

TOP NEWS: AstraZeneca Discontinues Alzheimer's Disease Treatment Trial

LONDON (Alliance News) - AstraZeneca PLC said Tuesday it has decided to discontinue trials of a new drug for Alzheimer's disease as the treatment is unlikely to meet its primary test UK listed

Read more
30 May 2018 13:51

Amati Global Investors Holds 11% Interest In IXICO After Transaction (ALLISS)

LONDON (Alliance News) - IXICO PLC said Amati Global Investors Ltd PLC held an 11% stake in the pharmaceutical company after a transaction on Wednesday.Prior to the transaction, Amati in if

Read more
23 May 2018 14:20

IXICO Confident 2018 Outlook As It Halves First-Half Loss

LONDON (Alliance News) - IXICO PLC said Wednesday it is confident it will deliver growth and meet 2018 market expectations as it halved its loss year-on-year.For the six months to March 31,

Read more
16 May 2018 16:29

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 17 May British LandFull Year Results3i GroupFull Year GridFull Year 18

Read more
14 May 2018 11:31

IXICO Signs New GBP1 Million 3-Year Contract With Existing Client

LONDON (Alliance News) - IXICO PLC said Monday it has signed a new GBP1 million contract with a pharmaceutical company.The neuroscience-focused digital technologies company said the with of

Read more
10 May 2018 14:23

IXICO To Net Additional GBP500,000 From Expansion Of Contracts

LONDON (Alliance News) - IXICO PLC said Thursday it will net additional GBP500,000 from expansion of existing clinical trial services contract with two biopharmaceutical companies.The an in

Read more
3 May 2018 10:38

IXICO To Place 19.6 Million New Shares To Raise GBP5.5 Million (ALLISS)

LONDON (Alliance News) - Neuroscience-focused technology company IXICO PLC said on Thursday it is to place new shares in a bid to raise GBP5.5 million.The company will issue 19.6 million at

Read more
4 Apr 2018 08:01

IXICO Extends Contract For Advanced Imaging Clinical Trial Services

LONDON (Alliance News) - IXICO PLC, the digital technologies company serving neuroscience, said Wednesday it has signed an extension to an existing contract with an unnamed 15

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.